Outcomes associated with carbapenem-sparing versus carbapenem-containing therapy for third-generation cephalosporin non-susceptible Serratia marcescens bacteremia: a retrospective cohort analysis
{{output}}
Background: Recent IDSA guidance supports carbapenem-sparing options for AmpC-producing Enterobacterales, but clinical evidence for third-generation cephalosporin non-susceptible (3 GC-NS) Serratia marcescens bloodstream infectio... ...
